• Accueil
• aspiration
• Risk of Aspiration Due to Dysphagia - TIGLUTIK (riluzole) - ALS Treatment

Risk of Aspiration Due to Dysphagia - TIGLUTIK (riluzole) - ALS Treatment

4.6 (619) · € 22.50 · En Stock

Aspiration pneumonia can be dangerous if left untreated. It is one of the leading causes of hospitalization and the second leading cause of death in ALS.

Benefits of TIGLUTIK - TIGLUTIK (riluzole) - ALS Treatment

PDF) Riluzole Oral Suspension for the Treatment of Amyotrophic Lateral Sclerosis: Texture and Compatibility with Food Thickeners Evaluation

Evaluation and Treatment of Swallowing Impairments

Frontiers Dysphagia in Amyotrophic Lateral Sclerosis: Impact on Patient Behavior, Diet Adaptation, and Riluzole Management

F-1/A

Incidence, risk factors, and sequelae of dysphagia mediated aspiration following lung transplantation - The Journal of Heart and Lung Transplantation

ALS & GBS Flashcards

J, Free Full-Text

TIGLUTIK is for People Who Have Difficulty Swallowing - TIGLUTIK (riluzole) - ALS Treatment

Risk of Aspiration Due to Dysphagia - TIGLUTIK (riluzole) - ALS Treatment

Dysphagia as the Initial Presenting Symptom of Amyotrophic Lateral Sclerosis

Frontiers Dysphagia in Amyotrophic Lateral Sclerosis: Impact on Patient Behavior, Diet Adaptation, and Riluzole Management

Safety and Clinical Benefits of Laryngeal Closure in Patients with Amyotrophic Lateral Sclerosis

fuuw - Flip eBook Pages 1-7

Amyotrophic Lateral Sclerosis (ALS)